CpG island methylation affects accessibility of the proximal BRCA1 promoter to transcription factors

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Breast Cancer Research and Treatment

• Publication date

  2010-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s10549-009-0422-1PMID 19466541PMCID PMC6697119
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The epigenomics of cancer.

  2007cited by this paper
• Estrogen receptor α, BRCA1, and FANCF promoter methylation occur in distinct subsets of sporadic breast cancers

  2007cited by this paper
• CTCF-dependent chromatin insulator is linked to epigenetic remodeling.

  2006cited by this paper
• Functional diversity of DNA methyltransferase inhibitors in human cancer cell lines.

  2006cited by this paper
• Epigenetic therapy of cancer: past, present and future

  2006cited by this paper
• Phase II study of low-dose decitabine in patients with chronic myelogenous leukemia resistant to imatinib mesylate.

  2005cited by this paper
• BRCA1 promoter methylation in sporadic breast tumors: relationship to gene expression profiles

  2005cited by this paper
• Comparison of biological effects of non-nucleoside DNA methylation inhibitors versus 5-aza-2′-deoxycytidine

  2005cited by this paper
• BRCA1 promoter methylation in sporadic breast cancer is associated with reduced BRCA1 copy number and chromosome 17 aneusomy.

  2005influential reference
• Hypoxia-induced down-regulation of BRCA1 expression by E2Fs.

  2005cited by this paper
• Continuous Zebularine Treatment Effectively Sustains Demethylation in Human Bladder Cancer Cells

  2004cited by this paper
• Preferential response of cancer cells to zebularine.

  2004cited by this paper
• Zebularine: a new drug for epigenetic therapy.

  2004cited by this paper
• DNA binding sites for putative methylation boundaries in the unmethylated region of the BRCA1 promoter

  2004cited by this paper
• Phase 1 study of low-dose prolonged exposure schedules of the hypomethylating agent 5-aza-2'-deoxycytidine (decitabine) in hematopoietic malignancies.

  2004cited by this paper
• Inhibition of DNA methylation and reactivation of silenced genes by zebularine.

  2003cited by this paper
• E2F6 Negatively Regulates BRCA1 in Human Cancer Cells without Methylation of Histone H3 on Lysine 9*

  2003cited by this paper
• Gene silencing in cancer in association with promoter hypermethylation.

  2003cited by this paper
• Reduced Brca1 protein expression in 2‐amino‐1‐methyl‐6‐phenylimidazo[4,5‐b]pyridine–induced rat mammary carcinomas

  2002cited by this paper
• Regulation of BRCA1 expression and its relationship to sporadic breast cancer

  2002influential reference
• The fundamental role of epigenetic events in cancer

  2002cited by this paper
• BRCA1 methylation: a significant role in tumour development?

  2002influential reference
• Loss of imprinting of the insulin-like growth factor II gene occurs by biallelic methylation in a core region of H19-associated CTCF-binding sites in colorectal cancer.

  2001cited by this paper
• Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

  2001cited by this paper
• CTCF-binding sites flank CTG/CAG repeats and form a methylation-sensitive insulator at the DM1 locus

  2001cited by this paper
• Binding of c-Myc to chromatin mediates mitogen-induced acetylation of histone H4 and gene activation.

  2001cited by this paper
• Low-dose 5-aza-2'-deoxycytidine, a DNA hypomethylating agent, for the treatment of high-risk myelodysplastic syndrome: a multicenter phase II study in elderly patients.

  2000cited by this paper
• Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors.

  2000cited by this paper
• CTCF mediates methylation-sensitive enhancer-blocking activity at the H19/Igf2 locus

  2000cited by this paper
• Methylation of the BRCA1 promoter is associated with decreased BRCA1 mRNA levels in clinical breast cancer specimens.

  2000cited by this paper
• Regulation of BRCA1 Expression by the Rb-E2F Pathway*

  2000cited by this paper
• Localization of human BRCA1 and its loss in high-grade, non-inherited breast carcinomas

  1999cited by this paper
• The protein CTCF is required for the enhancer blocking activity of vertebrate insulators.

  1999cited by this paper
• Frequency of breast cancer attributable to BRCA1 in a population-based series of American women.

  1998cited by this paper
• Aberrant methylation of the BRCA1 CpG island promoter is associated with decreased BRCA1 mRNA in sporadic breast cancer cells

  1998cited by this paper
• de la Chapelle, A.

  1997cited by this paper
• Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.

  1996cited by this paper
• BRCA1 mutations in primary breast and ovarian carcinomas.

  1994cited by this paper
• Toxicity of 5-aza-2'-deoxycytidine to mammalian cells is mediated primarily by covalent trapping of DNA methyltransferase rather than DNA demethylation.

  1994cited by this paper
• High-performance liquid chromatographic analysis of chemical stability of 5-aza-2'-deoxycytidine.

  1981cited by this paper

• Breast Cancer Disparities in African and African-Ancestry Populations: Genetics, Epigenetics, Structural Barriers and Technology-Enabled Solutions

  2026cites this paper
• Constitutional BRCA1 Epimutations: A Key for Understanding Basal-Like Breast and High-Grade Serous Ovarian Cancer

  2024cites this paper
• Hidden secrets of the cancer genome: unlocking the impact of non-coding mutations in gene regulatory elements

  2024cites this paper
• Spontaneous mutagenesis in human cells is controlled by REV1-Polymerase ζ and PRIMPOL.

  2023cites this paper
• MicroRNA-155-5p, Reduced by Curcumin-Re-Expressed Hypermethylated BRCA1, Is a Molecular Biomarker for Cancer Risk in BRCA1-methylation Carriers

  2023cites this paper
• Expression of BRCA1 by immunohistochemistry and its association with ER, PR, Her2neu status in infiltrative ductal carcinoma of breast

  2023cites this paper
• BRCA1 Promoter Hypermethylation in Malignant Breast Tumors and in the Histologically Normal Adjacent Tissues to the Tumors: Exploring Its Potential as a Biomarker and Its Clinical Significance in a Translational Approach

  2023cites this paper
• Can abnormal chromatin folding cause high-penetrance cancer predisposition?

  2022cites this paper
• Methylation-Sensitive Loop-Mediated Isothermal Amplification (LAMP): Nucleic Acid Methylation Detection through LAMP with Mobile Fluorescence Readout.

  2021cites this paper
• Curcumin induces re-expression of BRCA1 and suppression of γ synuclein by modulating DNA promoter methylation in breast cancer cell lines

  2020influential citation
• Epigenetic Activation of BRCA1 by Genistein In Vivo and Triple Negative Breast Cancer Cells Linked to Antagonism toward Aryl Hydrocarbon Receptor

  2019influential citation
• The anti-tumor effects of Mfn2 in breast cancer are dependent on promoter DNA methylation, the P21Ras motif and PKA phosphorylation site.

  2018cites this paper
• Effects of 5-Aza-2′-deoxycytidine (decitabine) on gene expression

  2018cites this paper
• Promoter methylation and Hoxd4 regulate UII mRNA tissue-specific expression in olive flounder (paralichthys olivaceus).

  2018cites this paper
• E2F1 interactive with BRCA1 pathway induces HCC two different small molecule metabolism or cell cycle regulation via mitochondrion or CD4+T to cytosol

  2018cites this paper
• Induction of the long noncoding RNA NBR2 from the bidirectional BRCA1 promoter under hypoxic conditions.

  2017cites this paper
• EZH2 contributes to the response to PARP inhibitors through its PARP-mediated poly-ADP ribosylation in breast cancer

  2017cites this paper
• The BRCA1 tumor suppressor: potential long-range interactions of the BRCA1 promoter and the risk of breast cancer

  2017cites this paper
• CRISPR-dCas9 mediated TET1 targeting for selective DNA demethylation at BRCA1 promoter

  2016cites this paper
• The dual specificity phosphatase 2 gene is hypermethylated in human cancer and regulated by epigenetic mechanisms

  2016cites this paper
• β‐catenin regulates c‐Myc and CDKN1A expression in breast cancer cells

  2016cites this paper
• Identifying long-range control elements of the BRCA1 promoter

  2015cites this paper
• Characterisation of novel protein partners of the CCCTC-binding factor in breast cancer cell lines

  2015cites this paper
• β-Catenin Is Required for the Tumorigenic Behavior of Triple-Negative Breast Cancer Cells

  2015cites this paper
• Expression of BRCA1 and BRCA2 proteins and their correlation with clinical staging in breast cancer.

  2015cites this paper
• Beyond the histone tale: HP1α deregulation in breast cancer epigenetics

  2015cites this paper
• BRCA1 germline mutation and glioblastoma development: report of cases

  2015cites this paper
• Functional deficiency of NBN, the Nijmegen breakage syndrome protein, in a p.R215W mutant breast cancer cell line

  2014cites this paper
• Identification of novel E2 binding sites within the HPV genome and their function in the regulation of viral gene expression

  2014cites this paper
• Companion Diagnostics and Cancer Biomarkers miR-185 Suppresses Tumor Proliferation by Directly Targeting E 2 F 6 and DNMT 1 and Indirectly Upregulating BRCA 1 in Triple-Negative Breast Cancer

  2014cites this paper
• miR-185 Suppresses Tumor Proliferation by Directly Targeting E2F6 and DNMT1 and Indirectly Upregulating BRCA1 in Triple-Negative Breast Cancer

  2014cites this paper
• Systematic screening reveals a role for BRCA1 in the response to transcription-associated DNA damage

  2014influential citation
• Identification of novel E 2 binding sites within the HPV genome and their function in the regulation of viral gene expression By

  2014cites this paper
• Nrf2 is associated with the regulation of basal transcription activity of the BRCA1 gene.

  2013cites this paper
• Differential methylation relative to breast cancer subtype and matched normal tissue reveals distinct patterns

  2013cites this paper
• Atlas of Genetics and Cytogenetics in Oncology and Haematology CTCF ( CCCTC-binding factor ( zinc finger protein ) )

  2013cites this paper
• Nrf 2 is associated with the regulation of basal transcription activity of the BRCA 1 gene

  2013cites this paper
• Epigenetic regulation of breast cancer type-1 gene by the activated aromatic hydrocarbon receptor and the preventative effects of resveratrol

  2012cites this paper
• Characterization of Glucocorticoid Receptor Promoter Methylation in Breast Cancer

  2012cites this paper
• BRCA1 promoter methylation status does not predict response to tamoxifen in sporadic breast cancer patients

  2012cites this paper
• Chromatin Insulators and Epigenetic Inheritance in Health and Disease

  2012cites this paper
• CTCF (CCCTC-binding factor (zinc finger protein))

  2012cites this paper
• The tumor suppressor role of CTCF

  2012cites this paper
• Integrated Systems and Technologies Ploidy and Large-Scale Genomic Instability Consistently Identify Basal-like Breast Carcinomas with BRCA 1 / 2 Inactivation

  2012cites this paper
• Dose-Dependent Activation of Putative Oncogene SBSN by BORIS

  2012cites this paper
• Ploidy and large-scale genomic instability consistently identify basal-like breast carcinomas with BRCA1/2 inactivation.

  2012cites this paper
• The dual lives of bidirectional promoters.

  2012cites this paper
• Tumour-specific methylation of PTPRG intron 1 locus in sporadic and Lynch syndrome colorectal cancer

  2011cites this paper
• Chromatin insulators: a role in nuclear organization and gene expression.

  2011cites this paper
• c-Myc activates BRCA1 gene expression through distal promoter elements in breast cancer cells

  2011cites this paper
• Involvement of MyoD and c-myb in regulation of basal and estrogen-induced transcription activity of the BRCA1 gene

  2011cites this paper
• Gene insulation. Part II: natural strategies in vertebrates.

  2010cites this paper
• Chromatin insulators: regulatory mechanisms and epigenetic inheritance.

  2008cites this paper
• induces re‑expression of BRCA1 and suppression of γ synuclein by modulating DNA promoter methylation in breast cancer cell lines

  year unknowninfluential citation